Telo Genomics Corp. (TDSGF)
USD 0.06
(-0.34%)
USD 0.06
(-0.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.92 Million CAD | 3.26% |
| 2022 | 2.83 Million CAD | -26.2% |
| 2021 | 3.83 Million CAD | 228.51% |
| 2020 | 1.16 Million CAD | 344.92% |
| 2019 | 262.66 Thousand CAD | -38.85% |
| 2018 | 429.51 Thousand CAD | -86.2% |
| 2017 | 3.11 Million CAD | 417.66% |
| 2016 | 601.31 Thousand CAD | 29.17% |
| 2015 | 465.53 Thousand CAD | -9.54% |
| 2014 | 514.62 Thousand CAD | -6.22% |
| 2013 | 548.76 Thousand CAD | 452.25% |
| 2012 | 99.36 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 856.53 Thousand CAD | -43.9% |
| 2024 Q2 | 1.52 Million CAD | -30.63% |
| 2024 Q1 | 2.2 Million CAD | -24.76% |
| 2023 Q1 | 2.25 Million CAD | -20.28% |
| 2023 Q2 | 1.62 Million CAD | -28.04% |
| 2023 Q3 | 979.58 Thousand CAD | -39.73% |
| 2023 FY | 2.92 Million CAD | 3.26% |
| 2023 Q4 | 2.92 Million CAD | 198.66% |
| 2022 Q3 | 3.31 Million CAD | -11.25% |
| 2022 FY | 2.83 Million CAD | -26.2% |
| 2022 Q1 | 3.92 Million CAD | 2.35% |
| 2022 Q2 | 3.73 Million CAD | -4.82% |
| 2022 Q4 | 2.83 Million CAD | -14.64% |
| 2021 FY | 3.83 Million CAD | 228.51% |
| 2021 Q1 | 1 Million CAD | -14.37% |
| 2021 Q2 | 1.82 Million CAD | 82.73% |
| 2021 Q3 | 2.16 Million CAD | 18.34% |
| 2021 Q4 | 3.83 Million CAD | 77.41% |
| 2020 Q3 | 1.24 Million CAD | -27.37% |
| 2020 FY | 1.16 Million CAD | 344.92% |
| 2020 Q2 | 1.71 Million CAD | 289.71% |
| 2020 Q1 | 439.57 Thousand CAD | 67.35% |
| 2020 Q4 | 1.16 Million CAD | -6.07% |
| 2019 FY | 262.66 Thousand CAD | -38.85% |
| 2019 Q3 | 321.93 Thousand CAD | 3.07% |
| 2019 Q2 | 312.35 Thousand CAD | -26.28% |
| 2019 Q4 | 262.66 Thousand CAD | -18.41% |
| 2019 Q1 | 423.71 Thousand CAD | -1.35% |
| 2018 Q1 | 2.05 Million CAD | -33.96% |
| 2018 FY | 429.51 Thousand CAD | -86.2% |
| 2018 Q4 | 429.51 Thousand CAD | -75.48% |
| 2018 Q3 | 1.75 Million CAD | -38.94% |
| 2018 Q2 | 2.86 Million CAD | 39.54% |
| 2017 Q2 | 6.61 Million CAD | 42.89% |
| 2017 Q4 | 3.11 Million CAD | -41.41% |
| 2017 Q1 | 4.62 Million CAD | 793.19% |
| 2017 FY | 3.11 Million CAD | 417.66% |
| 2017 Q3 | 5.31 Million CAD | -19.65% |
| 2016 Q3 | 559.68 Thousand CAD | -6.92% |
| 2016 Q2 | 601.31 Thousand CAD | -4.77% |
| 2016 Q4 | 518.06 Thousand CAD | -7.44% |
| 2016 FY | 601.31 Thousand CAD | 29.17% |
| 2016 Q1 | 631.45 Thousand CAD | 42.69% |
| 2015 Q4 | 442.53 Thousand CAD | -4.03% |
| 2015 Q2 | 465.53 Thousand CAD | -0.7% |
| 2015 Q3 | 461.11 Thousand CAD | -0.95% |
| 2015 FY | 465.53 Thousand CAD | -9.54% |
| 2015 Q1 | 468.79 Thousand CAD | -2.82% |
| 2014 Q3 | 528.77 Thousand CAD | 2.75% |
| 2014 FY | 514.62 Thousand CAD | -6.22% |
| 2014 Q1 | 518.67 Thousand CAD | -0.95% |
| 2014 Q4 | 482.38 Thousand CAD | -8.77% |
| 2014 Q2 | 514.62 Thousand CAD | -0.78% |
| 2013 Q3 | 547.43 Thousand CAD | -0.24% |
| 2013 Q1 | 549.45 Thousand CAD | -3.42% |
| 2013 Q2 | 548.76 Thousand CAD | -0.13% |
| 2013 FY | 548.76 Thousand CAD | 452.25% |
| 2013 Q4 | 523.66 Thousand CAD | -4.34% |
| 2012 Q4 | 568.94 Thousand CAD | -0.16% |
| 2012 FY | 99.36 Thousand CAD | 0.0% |
| 2012 Q3 | 569.84 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -130.542% |
| Arrayit Corporation | 1 Million USD | -192.444% |
| Atlantic International Corp. | 4.43 Million USD | 34.055% |
| Biocept, Inc. | 30.87 Million USD | 90.524% |
| Bioqual, Inc. | 56.58 Million USD | 94.83% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -1161.393% |
| DermTech, Inc. | 121.93 Million USD | 97.601% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.93% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 83.544% |
| iMD Companies, Inc. | 190.13 Thousand USD | -1438.667% |
| IDenta Corp. | 1.52 Million USD | -91.305% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 77.532% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 64.547% |
| InVitro International | 1.53 Million USD | -90.715% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 89.099% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -126438.711% |
| Medical Imaging Corp. | 4.19 Million USD | 30.204% |
| NovelStem International Corp. | 2.25 Million USD | -29.763% |
| Optigenex Inc. | 1.88 Million USD | -54.933% |
| PharmChem, Inc. | 2.76 Million USD | -5.786% |
| Proteome Sciences plc | 14.58 Million USD | 79.943% |
| Response Genetics, Inc | 48.88 Million USD | 94.015% |
| Rennova Health, Inc. | 20.57 Million USD | 85.779% |
| RushNet, Inc. | 6.04 Million USD | 51.624% |
| ScreenPro Security Inc. | 1.26 Million USD | -131.938% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -519.27% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -317.55% |
| Todos Medical Ltd. | 15.26 Million USD | 80.837% |